{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:51:50Z","timestamp":1794019910946,"version":"4.8.0"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Newborn screening (NBS) and its genetic version, genetic NBS (gNBS), are now used to identify a broad range of conditions, including metabolic, endocrine, and genetic disorders, leading to significant reductions in infant mortality and long-term complications. Advances in genomic technologies, particularly next-generation sequencing, have enhanced the ability to detect rare diseases early, using gNBS, improving long-term outcomes. The availability and scope of gNBS vary across countries, influenced by national policies and technological advancements. This systematic literature review aims to clarify the specific barriers, opportunities, and more general attitudes that stakeholders express about gNBS for rare diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main<\/jats:title>\n                    <jats:p>\n                      We extracted articles from 2010 to 2022. We followed the PRISMA guidelines and registered the review via PROSPERO (CRD42022297678). From an initial retrieval of 4519 records, two selection rounds resulted in a final list of 112 articles, which were assessed across different categories exploring various aspects of gNBS. The most important perceived opportunities in gNBS were the benefits of early intervention to reduce the burden of the diagnostic odyssey. The main identified barriers included three key codes: the stress and risk associated with false results and dealing with uncertainty (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200925), the psychosocial implications (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200926), and misunderstandings due to lack of education or communication. The majority of respondents expressed positive views, particularly regarding actionability.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The results indicate a generally favourable attitude toward newborn screening, with subtle variations in viewpoints. Our findings on these themes can specifically inform how final attitudes are shaped based on particular aspects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04179-0","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:52:55Z","timestamp":1767855175000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Preferences, attitudes and views regarding genetic newborn screening (gNBS) for rare diseases: a systematic review of the literature and synthesis from 2009 to 2022"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3706-7669","authenticated-orcid":false,"given":"Sylvia","family":"Martin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergana","family":"Kyosovska-Peshtenska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Audi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Zarakowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Grauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorien","family":"Veldwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"Hauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Coulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"F\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneta","family":"Piperkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith Sky","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Knieling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Gumus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martinez-Fresno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Granados","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan","family":"Sansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuen","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia Pia","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Silvio","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ottombrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Agolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Courbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsungai","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branimir","family":"Velinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Dubief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Raming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Saier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Fortunato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Frankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"8","key":"4179_CR1","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jama.1961.03040470079019","volume":"178","author":"R Guthrie","year":"1961","unstructured":"Guthrie R. Blood screening for phenylketonuria. Jama. 1961;178(8):863\u2013863.","journal-title":"Jama"},{"key":"4179_CR2","volume-title":"Newborn screening systems: the complete perspective","author":"CJ Driscoll","year":"2010","unstructured":"Driscoll CJ, McPherson B. Newborn screening systems: the complete perspective. Plural publishing; 2010."},{"issue":"2","key":"4179_CR3","first-page":"369","volume":"66","author":"NAV Fabie","year":"2019","unstructured":"Fabie NAV, Pappas KB, Feldman GL. The current state of newborn screening in the United States. Pediatr Clinics. 2019;66(2):369\u201386.","journal-title":"Pediatr Clinics"},{"issue":"3","key":"4179_CR4","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/ijns5030028","volume":"5","author":"A Bessey","year":"2019","unstructured":"Bessey A, et al. A cost-effectiveness analysis of newborn screening for severe combined immunodeficiency in the UK. Int J Neonatal Screening. 2019;5(3):28.","journal-title":"Int J Neonatal Screening"},{"issue":"10","key":"4179_CR5","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1002\/ajmg.a.36110","volume":"161a","author":"PS Kishnani","year":"2013","unstructured":"Kishnani PS, et al. Timing of diagnosis of patients with Pompe disease: data from the Pompe registry. Am J Med Genet A. 2013;161a(10):2431\u201343.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"4179_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1080\/10245332.2016.1240391","volume":"22","author":"L Nalysnyk","year":"2017","unstructured":"Nalysnyk L, et al. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017;22(2):65\u201373.","journal-title":"Hematology"},{"key":"4179_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01783-8","volume":"16","author":"K Vill","year":"2021","unstructured":"Vill K, et al. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years. Orphanet J Rare Dis. 2021;16:1\u201310.","journal-title":"Orphanet J Rare Dis"},{"key":"4179_CR8","unstructured":"Koppaka R. Ten Great public health achievements-United States, 2001-2010. 2011."},{"key":"4179_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s12687-012-0118-9","volume":"4","author":"J Forman","year":"2013","unstructured":"Forman J, et al. Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening. J Community Genet. 2013;4:59\u201367.","journal-title":"J Community Genet"},{"key":"4179_CR10","doi-asserted-by":"crossref","unstructured":"Mittal AK, et al. Next-generation sequencing in newborn screening: a review on clinical and economic prospects. Open Biotechnol J. 2023;17(1).","DOI":"10.2174\/18740707-v16-e221213-2022-6"},{"key":"4179_CR11","doi-asserted-by":"crossref","unstructured":"Remec ZI, et al. Next-generation sequencing in newborn screening: a review of current state. Frontiers in genetics. 2021;12:662254.","DOI":"10.3389\/fgene.2021.662254"},{"issue":"1","key":"4179_CR12","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/10408363.2020.1781778","volume":"58","author":"Y Gonz\u00e1lez-Irazabal","year":"2021","unstructured":"Gonz\u00e1lez-Irazabal Y, de Abajo GH, Mart\u00ednez-Morillo E. Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies. Crit Rev In Clin Lab Sci. 2021;58(1):29\u201348.","journal-title":"Crit Rev In Clin Lab Sci"},{"issue":"10","key":"4179_CR13","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1111\/apa.15974","volume":"110","author":"SC Groft","year":"2021","unstructured":"Groft SC, Posada M, Taruscio D. Progress, challenges and global approaches to rare diseases. Acta paediatrica. 2021;110(10):2711\u201316.","journal-title":"Acta paediatrica"},{"issue":"7","key":"4179_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/gim.2013.73","volume":"15","author":"RC Green","year":"2013","unstructured":"Green RC, et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet in Med. 2013;15(7):565\u201374.","journal-title":"Genet in Med"},{"issue":"11","key":"4179_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/s41576-023-00621-w","volume":"24","author":"Z Stark","year":"2023","unstructured":"Stark Z, Scott RH. Genomic newborn screening for rare diseases. Nat Rev Genet. 2023;24(11):755\u201366.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"4179_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41436-018-0034-4","volume":"21","author":"J Richer","year":"2019","unstructured":"Richer J, Laberge A-M. Secondary findings from next-generation sequencing: what does actionable in childhood really mean? Genet in Med. 2019;21(1):124\u201332.","journal-title":"Genet in Med"},{"key":"4179_CR17","doi-asserted-by":"crossref","unstructured":"Gold NB, et al. Perspectives of rare disease experts on newborn genome sequencing. jama network open. 2023;6(5):e2312231\u20132312231.","DOI":"10.1001\/jamanetworkopen.2023.12231"},{"key":"4179_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s12687-011-0046-0","volume":"2","author":"MH Araia","year":"2011","unstructured":"Araia MH, Potter BK. Newborn screening education on the internet: a content analysis of North American newborn screening program websites. J Community Genet. 2011;2:127\u201334.","journal-title":"J Community Genet"},{"issue":"4","key":"4179_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/ijns8040053","volume":"8","author":"A Tluczek","year":"2022","unstructured":"Tluczek A, Ersig AL, Lee S. Psychosocial issues related to newborn screening: a systematic review and synthesis. Int J Neonatal Screening. 2022;8(4):53.","journal-title":"Int J Neonatal Screening"},{"issue":"3","key":"4179_CR20","doi-asserted-by":"publisher","first-page":"e233","DOI":"10.1016\/j.pedn.2015.11.010","volume":"31","author":"M Jessup","year":"2016","unstructured":"Jessup M, et al. Parental experience of information and education processes following diagnosis of their infant with cystic fibrosis via newborn screening. J Pediatr Nurs. 2016;31(3):e233\u201341.","journal-title":"J Pediatr Nurs"},{"issue":"2","key":"4179_CR21","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/14636778.2022.2091533","volume":"41","author":"CC Clark","year":"2022","unstructured":"Clark CC, Boardman FK. Expanding the notion of \u201cbenefit\u201d: comparing public, parent, and professional attitudes towards whole genome sequencing in newborns. New Genet Soc. 2022;41(2):96\u2013115.","journal-title":"New Genet And Soc"},{"issue":"1","key":"4179_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijns9010015","volume":"9","author":"G Marca","year":"2023","unstructured":"Marca G, et al. Current state and innovations in newborn screening: continuing to do good and avoid harm. Int J Neonatal Screening. 2023;9(1):15.","journal-title":"Int J Neonatal Screening"},{"issue":"9","key":"4179_CR23","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/genes11091018","volume":"11","author":"R Yahyaoui","year":"2020","unstructured":"Yahyaoui R, et al. Metabolic serendipities of expanded newborn screening. Genes. 2020;11(9):1018.","journal-title":"Genes"},{"issue":"1","key":"4179_CR24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/ijns7010015","volume":"7","author":"JG Loeber","year":"2021","unstructured":"Loeber JG, et al. Neonatal screening in Europe revisited: an ISNS perspective on the current state and developments since 2010. Int J Neonatal Screening. 2021;7(1):15.","journal-title":"Int J Neonatal Screening"},{"key":"4179_CR25","first-page":"13","volume-title":"Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe","author":"M Scarpa","year":"2022","unstructured":"Scarpa M, et al. Newborn screening as a fully integrated system to stimulate equity in neonatal screening in Europe. Lancet Regional Health-Europe; 2022. p. 13."},{"issue":"2\u20133","key":"4179_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s10545-006-0259-2","volume":"29","author":"RJ Pollitt","year":"2006","unstructured":"Pollitt RJ. International perspectives on newborn screening. J Inherited Metabolic Disease. 2006;29(2\u20133):390\u201396.","journal-title":"J Inherited Metabolic Disease"},{"issue":"2","key":"4179_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/ijns8020031","volume":"8","author":"J Sikonja","year":"2022","unstructured":"Sikonja J, et al. Towards achieving equity and innovation in newborn screening across Europe. Int J Neonatal Screening. 2022;8(2):31.","journal-title":"Int J Neonatal Screening"},{"key":"4179_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12920-017-0247-4","volume":"10","author":"JM Friedman","year":"2017","unstructured":"Friedman JM, et al. Genomic newborn screening: public health policy considerations and recommendations. BMC Med Genomics. 2017;10:1\u201313.","journal-title":"BMC Med Genomics"},{"key":"4179_CR29","doi-asserted-by":"crossref","unstructured":"Higgins JP, Green S, editors. Cochrane handbook for systematic reviews of interventions. 2008.","DOI":"10.1002\/9780470712184"},{"key":"4179_CR30","doi-asserted-by":"crossref","unstructured":"Braun V, Clarke V. Using thematic analysis in psychology. Qualitative research in psychology. 2006;3(2):77\u2013101.","DOI":"10.1191\/1478088706qp063oa"},{"key":"4179_CR31","doi-asserted-by":"crossref","unstructured":"Kuckartz U. Qualitative text analysis: a guide to methods, practice and using software. Qualitative Text Anal. 2013;1\u2013192.","DOI":"10.4135\/9781446288719"},{"key":"4179_CR32","first-page":"33","volume-title":"Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice","author":"S Lombardo","year":"2023","unstructured":"Lombardo S, et al. Policy-making and implementation for newborn bloodspot screening in Europe: a comparison between EURORDIS principles and UK practice. Lancet Regional Health-Europe; 2023. p. 33."},{"key":"4179_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13052-015-0147-1","volume":"41","author":"AB Burlina","year":"2015","unstructured":"Burlina AB, Corsello G. Survey of Italian pediatricians\u2019 perspectives and knowledge about neonatal screening. Italian J Pediatrics. 2015;41:1\u20134.","journal-title":"Italian J Pediatrics"},{"issue":"2","key":"4179_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijns5020023","volume":"5","author":"F Johnson","year":"2019","unstructured":"Johnson F, Southern KW, Ulph F. Psychological impact on parents of an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis: a qualitative study. Int J Neonatal Screening. 2019;5(2):23.","journal-title":"Int J Neonatal Screening"},{"key":"4179_CR35","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10897-015-9879-8","volume":"25","author":"EC Lisi","year":"2016","unstructured":"Lisi EC, McCandless SE. Newborn screening for lysosomal storage disorders: views of genetic healthcare providers. J Genetic Couns. 2016;25:373\u201384.","journal-title":"J Genetic Couns"},{"key":"4179_CR36","doi-asserted-by":"crossref","unstructured":"Stark AP, Lang CW, Ross LF. A pilot study to evaluate knowledge and attitudes of Illinois pediatricians toward newborn screening for sickle cell disease and cystic fibrosis. Am J Perinatology. 2010;169\u201376.","DOI":"10.1055\/s-0030-1265828"},{"key":"4179_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jpeds.2020.03.027","volume":"224","author":"MH Farrell","year":"2020","unstructured":"Farrell MH, et al. Experience with parent follow-up for communication outcomes after newborn screening identifies carrier status. J Pediatrics. 2020;224:37\u201343. e2.","journal-title":"The J Pediatrics"},{"key":"4179_CR38","doi-asserted-by":"crossref","unstructured":"Hayeems RZ, et al. False-positive newborn screening for cystic fibrosis and health care use. Pediatrics. 2017;140(5).","DOI":"10.1542\/peds.2017-0604"},{"key":"4179_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-016-0391-5","volume":"11","author":"MD Karaceper","year":"2016","unstructured":"Karaceper MD, et al. The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study. Orphanet J Rare Dis. 2016;11:1\u20139.","journal-title":"Orphanet J Rare Dis"},{"issue":"Supplement_1","key":"4179_CR40","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1542\/peds.2015-3731G","volume":"137","author":"SE Waisbren","year":"2016","unstructured":"Waisbren SE, et al. Psychosocial factors influencing parental interest in genomic sequencing of newborns. Pediatrics. 2016;137(Supple 1):S30\u201335.","journal-title":"Pediatrics"},{"issue":"11","key":"4179_CR41","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamapediatrics.2021.2829","volume":"175","author":"S Pereira","year":"2021","unstructured":"Pereira S, et al. Psychosocial effect of newborn genomic sequencing on families in the BabySeq Project: a randomized clinical trial. JAMA Pediatrics. 2021;175(11):1132\u201341.","journal-title":"JAMA Pediatrics"},{"issue":"1","key":"4179_CR42","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/jgc4.1475","volume":"31","author":"TS Schwartz","year":"2022","unstructured":"Schwartz TS, et al. Effects of participation in a US trial of newborn genomic sequencing on parents at risk for depression. J Genetic Couns. 2022;31(1):218\u201329.","journal-title":"J Genetic Couns"},{"issue":"4","key":"4179_CR43","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ijns8040054","volume":"8","author":"MH Farrell","year":"2022","unstructured":"Farrell MH, et al. Parental preferences about Policy options regarding disclosure of incidental genetic findings in newborn screening: using videos and the internet to educate and obtain input. Int J Neonatal Screening. 2022;8(4):54.","journal-title":"Int J Neonatal Screening"},{"issue":"4","key":"4179_CR44","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jval.2016.11.007","volume":"20","author":"SJ Wright","year":"2017","unstructured":"Wright SJ, et al. Eliciting preferences for information provision in newborn bloodspot screening programs. Value In Health. 2017;20(4):651\u201361.","journal-title":"Value In Health"},{"issue":"6","key":"4179_CR45","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1002\/jgc4.1615","volume":"31","author":"S Prakash","year":"2022","unstructured":"Prakash S, et al. Newborn screening for Pompe disease: parental experiences and follow-up care for a late-onset diagnosis. J Genetic Couns. 2022;31(6):1404\u201320.","journal-title":"J Genetic Couns"},{"issue":"2","key":"4179_CR46","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1542\/peds.2015-0414","volume":"136","author":"DB Bailey Jr","year":"2015","unstructured":"Bailey DB Jr, et al. Maternal consequences of the detection of fragile X carriers in newborn screening. Pediatrics. 2015;136(2):e433\u201340.","journal-title":"Pediatrics"},{"issue":"5","key":"4179_CR47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/nur.20452","volume":"34","author":"A Tluczek","year":"2011","unstructured":"Tluczek A, McKechnie AC, Brown RL. Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results. Res In Nurs Health. 2011;34(5):389\u2013400.","journal-title":"Res In Nurs Health"},{"issue":"4","key":"4179_CR48","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1542\/peds.2010-0217","volume":"126","author":"EA Lipstein","year":"2010","unstructured":"Lipstein EA, et al. Parents\u2019 decision-making in newborn screening: opinions, choices, and information needs. Pediatrics. 2010;126(4):696\u2013704.","journal-title":"Pediatrics"},{"issue":"4","key":"4179_CR49","doi-asserted-by":"publisher","first-page":"e36235","DOI":"10.1371\/journal.pone.0036235","volume":"7","author":"W-J Tu","year":"2012","unstructured":"Tu W-J, et al. Psychological effects of false-positive results in expanded newborn screening in China. PLoS One. 2012;7(4):e36235.","journal-title":"PLoS One"},{"key":"4179_CR50","volume-title":"Parents\u2019 experiences of expanded newborn screening","author":"JM DeLuca","year":"2010","unstructured":"DeLuca JM. Parents\u2019 experiences of expanded newborn screening. University of Rochester School of Nursing; 2010."},{"issue":"4","key":"4179_CR51","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1542\/peds.2010-2448","volume":"128","author":"BA Tarini","year":"2011","unstructured":"Tarini BA, et al. False-positive newborn screening result and future health care use in a state medicaid cohort. Pediatrics. 2011;128(4):715\u201322.","journal-title":"Pediatrics"},{"issue":"3","key":"4179_CR52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/ijns8030043","volume":"8","author":"K Crossen","year":"2022","unstructured":"Crossen K, et al. A qualitative study: mothers\u2019 experiences of their child\u2019s late-onset Pompe disease diagnosis following newborn screening. Int J Neonatal Screening. 2022;8(3):43.","journal-title":"Int J Neonatal Screening"},{"key":"4179_CR53","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.3389\/fimmu.2019.02438","volume":"10","author":"M Blom","year":"2019","unstructured":"Blom M, et al. Dilemma of reporting incidental findings in newborn screening programs for SCID: parents\u2019 perspective on ataxia telangiectasia. Front Immunol. 2019;10:2438.","journal-title":"Front Immunol"},{"issue":"1","key":"4179_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12887-022-03160-1","volume":"22","author":"M Conway","year":"2022","unstructured":"Conway M, et al. Pain points in parents\u2019 interactions with newborn screening systems: a qualitative study. BMC Pediatrics. 2022;22(1):167.","journal-title":"BMC Pediatrics"},{"issue":"1","key":"4179_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1542\/peds.2010-3413","volume":"128","author":"JM DeLuca","year":"2011","unstructured":"DeLuca JM, et al. Parents\u2019 experiences of expanded newborn screening evaluations. Pediatrics. 2011;128(1):53\u201361.","journal-title":"Pediatrics"},{"issue":"12","key":"4179_CR56","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1111\/j.1651-2227.2009.01485.x","volume":"98","author":"S Perobelli","year":"2009","unstructured":"Perobelli S, et al. Inconclusive cystic fibrosis neonatal screening results: long-term psychosocial effects on parents. Acta paediatrica. 2009;98(12):1927\u201334.","journal-title":"Acta paediatrica"},{"key":"4179_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12887-017-0873-1","volume":"17","author":"L Moody","year":"2017","unstructured":"Moody L, et al. Healthcare professionals\u2019 and parents\u2019 experiences of the confirmatory testing period: a qualitative study of the UK expanded newborn screening pilot. BMC Pediatrics. 2017;17:1\u201310.","journal-title":"BMC Pediatrics"},{"issue":"2","key":"4179_CR58","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/gim.0b013e31822dd7b8","volume":"14","author":"A La Pean","year":"2012","unstructured":"La Pean A, et al. A qualitative secondary evaluation of statewide follow-up interviews for abnormal newborn screening results for cystic fibrosis and sickle cell hemoglobinopathy. Genet in Med. 2012;14(2):207\u201314.","journal-title":"Genet in Med"},{"issue":"10","key":"4179_CR59","doi-asserted-by":"publisher","first-page":"e037081","DOI":"10.1136\/bmjopen-2020-037081","volume":"10","author":"J Chudleigh","year":"2020","unstructured":"Chudleigh J, et al. Qualitative exploration of health professionals\u2019 experiences of communicating positive newborn bloodspot screening results for nine conditions in England. BMJ Open. 2020;10(10):e037081.","journal-title":"BMJ Open"},{"key":"4179_CR60","doi-asserted-by":"crossref","unstructured":"Cyrus A, et al. Clinic-based infant screening for Duchenne muscular dystrophy: a feasibility study. PLoS Curr. 2012;4.","DOI":"10.1371\/4f99c5654147a"},{"issue":"2","key":"4179_CR61","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12687-021-00572-x","volume":"13","author":"A Kasem","year":"2022","unstructured":"Kasem A, et al. Mothers\u2019 knowledge and attitudes about newborn screening in Jordan. J Community Genet. 2022;13(2):215\u201325.","journal-title":"J Community Genet"},{"key":"4179_CR62","unstructured":"Ong BAG, et al. Knowledge, attitudes, and awareness towards newborn screening in Association with Received prenatal care: a Survey of primiparous postpartum mothers at the Philippine general Hospital. Acta Medica Philippina. 2022;56(7)."},{"key":"4179_CR63","doi-asserted-by":"publisher","first-page":"891592","DOI":"10.3389\/fgene.2022.891592","volume":"13","author":"HL Peay","year":"2022","unstructured":"Peay HL, et al. Education and consent for population-based DNA screening: a mixed-methods evaluation of the early check newborn screening pilot study. Front Genet. 2022;13:891592.","journal-title":"Front Genet"},{"issue":"8","key":"4179_CR64","doi-asserted-by":"publisher","first-page":"e0272585","DOI":"10.1371\/journal.pone.0272585","volume":"17","author":"SM van der Pal","year":"2022","unstructured":"van der Pal SM, et al. Parents\u2019 views on accepting, declining, and expanding newborn bloodspot screening. PLoS One. 2022;17(8):e0272585.","journal-title":"PLoS One"},{"issue":"6","key":"4179_CR65","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2217\/pme-2016-0066","volume":"13","author":"CH Wade","year":"2016","unstructured":"Wade CH, Elliott KR. Young adults\u2019 attitudes toward pediatric whole-genome sequencing. Personalized Med. 2016;13(6):541\u201352.","journal-title":"Personalized Med"},{"issue":"11","key":"4179_CR66","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1002\/ajmg.a.33074","volume":"149","author":"CW Lang","year":"2009","unstructured":"Lang CW, et al. Maternal knowledge and attitudes about newborn screening for sickle cell disease and cystic fibrosis. Am J Med Genet Part A. 2009;149(11):2424\u201329.","journal-title":"Am J Med Genet Part A"},{"issue":"1","key":"4179_CR67","doi-asserted-by":"publisher","first-page":"238146831774617","DOI":"10.1177\/2381468317746170","volume":"3","author":"SJ Wright","year":"2018","unstructured":"Wright SJ, et al. Understanding midwives\u2019 preferences for providing information about newborn bloodspot screening. MDM Policy Pract. 2018;3(1):2381468317746170.","journal-title":"MDM Policy Pract"},{"key":"4179_CR68","doi-asserted-by":"publisher","first-page":"875229","DOI":"10.3389\/fped.2022.875229","volume":"10","author":"X Wu","year":"2022","unstructured":"Wu X, et al. Are we ready for newborn genetic screening? A cross-sectional Survey of healthcare professionals in Southeast China. Front Pediatrics. 2022;10:875229.","journal-title":"Front Pediatrics"},{"issue":"6","key":"4179_CR69","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1007\/s10897-018-0258-0","volume":"27","author":"K Leppert","year":"2018","unstructured":"Leppert K, et al. Genetic counselors\u2019 experience with and opinions on the management of newborn screening incidental carrier findings. J Genetic Couns. 2018;27(6):1328\u201340.","journal-title":"J Genetic Couns"},{"issue":"4","key":"4179_CR70","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1177\/1367493512443906","volume":"16","author":"N Salm","year":"2012","unstructured":"Salm N, Yetter E, Tluczek A. Informing parents about positive newborn screen results: parents\u2019 recommendations. J Child Health Care. 2012;16(4):367\u201381.","journal-title":"J Child Health Care"},{"issue":"3","key":"4179_CR71","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10897-014-9767-7","volume":"24","author":"R Temme","year":"2015","unstructured":"Temme R, et al. Assessment of parental understanding of positive newborn screening results and carrier status for cystic fibrosis with the use of a short educational video. J Genetic Couns. 2015;24(3):473\u201381.","journal-title":"J Genetic Couns"},{"key":"4179_CR72","doi-asserted-by":"publisher","first-page":"524796","DOI":"10.3389\/fimmu.2020.00885","volume":"11","author":"M Raspa","year":"2020","unstructured":"Raspa M, et al. Information and emotional support needs of families whose infant was diagnosed with SCID through newborn screening. Front Immunol. 2020;11:524796.","journal-title":"Front Immunol"},{"key":"4179_CR73","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1007\/s10897-016-9959-4","volume":"25","author":"J Chudleigh","year":"2016","unstructured":"Chudleigh J, et al. Parents\u2019 experiences of receiving the initial positive newborn screening (NBS) result for cystic fibrosis and sickle cell disease. J Genetic Couns. 2016;25:1215\u201326.","journal-title":"J Genetic Couns"},{"issue":"5","key":"4179_CR74","doi-asserted-by":"publisher","first-page":"e2021053454","DOI":"10.1542\/peds.2021-053454","volume":"149","author":"AM Sims","year":"2022","unstructured":"Sims AM, et al. Parents\u2019 experiences and needs regarding infant sickle cell trait results. Pediatrics. 2022;149(5):e2021053454.","journal-title":"Pediatrics"},{"issue":"4","key":"4179_CR75","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1002\/ajmg.a.32725","volume":"149","author":"K Acharya","year":"2009","unstructured":"Acharya K, Ross LF. Fragile X screening: attitudes of genetic health professionals. Am J Med Genet Part A. 2009;149(4):626\u201332.","journal-title":"Am J Med Genet Part A"},{"issue":"6","key":"4179_CR76","doi-asserted-by":"publisher","first-page":"439","DOI":"10.46747\/cfp.6706439","volume":"67","author":"RZ Hayeems","year":"2021","unstructured":"Hayeems RZ, et al. Primary care providers\u2019 role in newborn screening result notification for cystic fibrosis. Can Fam Physician. 2021;67(6):439\u201348.","journal-title":"Can Fam Physician"},{"issue":"8","key":"4179_CR77","first-page":"861","volume":"59","author":"RZ Hayeems","year":"2013","unstructured":"Hayeems RZ, et al. Primary care role in expanded newborn screening: after the heel prick test. Can Fam Physician. 2013;59(8):861\u201368.","journal-title":"Can Fam Physician"},{"issue":"1","key":"4179_CR78","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/ijns5010003","volume":"5","author":"S Bansal","year":"2018","unstructured":"Bansal S, Kasturi K, Chin VL. National survey assessment of the United States\u2019 pediatric residents\u2019 knowledge, attitudes, and practices regarding newborn screening. Int J Neonatal Screening. 2018;5(1):3.","journal-title":"Int J Neonatal Screening"},{"issue":"1","key":"4179_CR79","doi-asserted-by":"publisher","first-page":"e33485","DOI":"10.2196\/33485","volume":"14","author":"J Chudleigh","year":"2022","unstructured":"Chudleigh J, et al. Co-designing improved communication of newborn bloodspot screening results to parents: mixed methods study. J Participatory Med. 2022;14(1):e33485.","journal-title":"J Participatory Med"},{"issue":"3","key":"4179_CR80","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41436-019-0670-3","volume":"22","author":"PJ Azzopardi","year":"2020","unstructured":"Azzopardi PJ, et al. Health-care providers\u2019 perspectives on uncertainty generated by variant forms of newborn screening targets. Genet in Med. 2020;22(3):566\u201373.","journal-title":"Genet in Med"},{"issue":"9","key":"4179_CR81","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1093\/pch\/15.9.590","volume":"15","author":"M Lilley","year":"2010","unstructured":"Lilley M, et al. Newborn screening for cystic fibrosis in Alberta: two years of experience. Paediatr Child Health. 2010;15(9):590\u201394.","journal-title":"Paediatr Child Health"},{"issue":"1","key":"4179_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02474-8","volume":"17","author":"X Wang","year":"2022","unstructured":"Wang X, et al. Current attitudes and preconceptions on newborn genetic screening in the Chinese reproductive-aged population. Orphanet J Rare Dis. 2022;17(1):1\u201310.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4179_CR83","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1542\/peds.2009-0269","volume":"125","author":"AM Plass","year":"2010","unstructured":"Plass AM, et al. Neonatal screening for treatable and untreatable disorders: prospective parents\u2019 opinions. Pediatrics. 2010;125(1):e99\u2013106.","journal-title":"Pediatrics"},{"issue":"1\u20132","key":"4179_CR84","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2021.09.001","volume":"134","author":"L Davids","year":"2021","unstructured":"Davids L, et al. Health care practitioners\u2019 experience-based opinions on providing care after a positive newborn screen for Pompe disease. Mol Genet Metab. 2021;134(1\u20132):20\u201328.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"4179_CR85","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1002\/ppul.25586","volume":"56","author":"Y Gokdemir","year":"2021","unstructured":"Gokdemir Y, et al. Geographical barriers to timely diagnosis of cystic fibrosis and anxiety level of parents during newborn screening in Turkey. Pediatr Pulmonol. 2021;56(10):3223\u201331.","journal-title":"Pediatr Pulmonol"},{"key":"4179_CR86","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.socscimed.2016.07.036","volume":"166","author":"RS Paquin","year":"2016","unstructured":"Paquin RS, et al. Parental intentions to enroll children in a voluntary expanded newborn screening program. Soc Sciamp; Med. 2016;166:17\u201324.","journal-title":"Soc Sciamp; Med"},{"issue":"1","key":"4179_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-7-15","volume":"7","author":"SS Weinreich","year":"2012","unstructured":"Weinreich SS, et al. Public support for neonatal screening for Pompe disease, a broad-phenotype condition. Orphanet J Rare Dis. 2012;7(1):1\u201313.","journal-title":"Orphanet J Rare Dis"},{"issue":"5\u20136","key":"4179_CR88","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000526382","volume":"25","author":"GT Timmins","year":"2022","unstructured":"Timmins GT, et al. Diverse parental perspectives of the social and educational needs for expanding newborn screening through genomic sequencing. Public Health Genomics. 2022;25(5\u20136):185\u201392.","journal-title":"Public Health Genomics"},{"issue":"Supplement_1","key":"4179_CR89","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1542\/peds.2015-3731H","volume":"137","author":"G Joseph","year":"2016","unstructured":"Joseph G, et al. Parental views on expanded newborn screening using whole-genome sequencing. Pediatrics. 2016;137(Supplement_1):S36\u201346.","journal-title":"Pediatrics"},{"issue":"3","key":"4179_CR90","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ejhg.2009.173","volume":"18","author":"FA Miller","year":"2010","unstructured":"Miller FA, et al. Understanding sickle cell carrier status identified through newborn screening: a qualitative study. Eur J Hum Genet. 2010;18(3):303\u201308.","journal-title":"Eur J Hum Genet"},{"issue":"4\u20135","key":"4179_CR91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/13557858.2011.556245","volume":"16","author":"F Ulph","year":"2011","unstructured":"Ulph F, et al. Familial influences on antenatal and newborn haemoglobinopathy screening. Ethnicity Health. 2011;16(4\u20135):361\u201375.","journal-title":"Ethnicity Health"},{"issue":"11","key":"4179_CR92","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/ejhg.2014.22","volume":"22","author":"Y Bombard","year":"2014","unstructured":"Bombard Y, et al. Public views on participating in newborn screening using genome sequencing. Eur J Hum Genet. 2014;22(11):1248\u201354.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4179_CR93","first-page":"99","volume":"6","author":"FK Boardman","year":"2018","unstructured":"Boardman FK, Sadler C, Young PJ. Newborn genetic screening for spinal muscular atrophy in the UK: the views of the general population. Mol Genet & Evidence Med. 2018;6(1):99\u2013108.","journal-title":"Mol Genet & Evidence Med"},{"issue":"1","key":"4179_CR94","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3390\/ijns8010011","volume":"8","author":"AJ Goldenberg","year":"2022","unstructured":"Goldenberg AJ, et al. Genomics and newborn screening: perspectives of public health programs. Int J Neonatal Screening. 2022;8(1):11.","journal-title":"Int J Neonatal Screening"},{"issue":"2","key":"4179_CR95","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/jgc4.1645","volume":"32","author":"M Cao","year":"2023","unstructured":"Cao M, et al. Australian healthcare professionals\u2019 perspectives on the ethical and practical issues associated with genomic newborn screening. J Genetic Couns. 2023;32(2):376\u201386.","journal-title":"J Genetic Couns"},{"key":"4179_CR96","first-page":"S2","volume-title":"On what we have learned and still need to learn about the psychosocial impacts of genetic testing","author":"E Parens","year":"2019","unstructured":"Parens E, Appelbaum PS. On what we have learned and still need to learn about the psychosocial impacts of genetic testing. Wiley Online Library; 2019. p. S2\u20139."},{"key":"4179_CR97","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.clim.2019.03.012","volume":"202","author":"C Thomas","year":"2019","unstructured":"Thomas C, et al. Clinical and economic aspects of newborn screening for severe combined immunodeficiency: DEPISTREC study results. Clin Immunol. 2019;202:33\u201339.","journal-title":"Clin Immunol"},{"issue":"1","key":"4179_CR98","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/jgc4.1480","volume":"31","author":"L Peterson","year":"2022","unstructured":"Peterson L, et al. A qualitative assessment of parental experiences with false-positive newborn screening for Krabbe disease. J Genetic Couns. 2022;31(1):252\u201360.","journal-title":"J Genetic Couns"},{"issue":"1","key":"4179_CR99","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/gim.0b013e31822ebaa6","volume":"14","author":"DB Bailey Jr","year":"2012","unstructured":"Bailey DB Jr, et al. Caregiver opinions about fragile X population screening. Genet in Med. 2012;14(1):115\u201321.","journal-title":"Genet in Med"},{"key":"4179_CR100","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s10545-018-0159-2","volume":"41","author":"B Pruniski","year":"2018","unstructured":"Pruniski B, Lisi E, Ali N. Newborn screening for Pompe disease: impact on families. J Inherited Metabolic Disease. 2018;41:1189\u2013203.","journal-title":"J Inherited Metabolic Disease"},{"issue":"11","key":"4179_CR101","first-page":"1163","volume":"101","author":"K Acharya","year":"2009","unstructured":"Acharya K, Lang CW, Ross LF. A pilot study to explore knowledge, attitudes, and beliefs about sickle cell trait and disease. J Natl Med Assoc. 2009;101(11):1163\u201372.","journal-title":"J Natl Med Assoc"},{"issue":"10","key":"4179_CR102","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1089\/gtmb.2010.0232","volume":"15","author":"F Vansenne","year":"2011","unstructured":"Vansenne F, et al. Providing genetic risk information to parents of newborns with sickle cell trait: role of the general practitioner in neonatal screening. Genetic Test Mol Biomarker. 2011;15(10):671\u201375.","journal-title":"Genetic Test And Mol Biomarker"},{"issue":"5\u20136","key":"4179_CR103","first-page":"299","volume":"104","author":"J Koopmans","year":"2012","unstructured":"Koopmans J, Ross LF. Identification and management of sickle cell trait by young physicians. J Natl Med Assoc. 2012;104(5\u20136):299\u2013304.","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"4179_CR104","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1352\/1944-7558-188.4.284","volume":"118","author":"K Acharya","year":"2013","unstructured":"Acharya K, Schindler A. Developmental and behavioral pediatricians\u2019 attitudes toward screening for fragile X. Am J On Intellect And Dev Disabilities. 2013;118(4):284\u201393.","journal-title":"Am J On Intellect And Dev Disabilities"},{"key":"4179_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12687-020-00482-4","volume":"12","author":"D Bukini","year":"2021","unstructured":"Bukini D, et al. Influence of gender norms in relation to child\u2019s quality of care: follow-up of families of children with SCD identified through NBS in Tanzania. J Community Genet. 2021;12:143\u201354.","journal-title":"J Community Genet"},{"key":"4179_CR106","first-page":"373","volume-title":"Sample size requirements for discrete-choice experiments in healthcare: a practical guide","author":"EW de Bekker-Grob","year":"2015","unstructured":"de Bekker-Grob EW, et al. Sample size requirements for discrete-choice experiments in healthcare: a practical guide. Vol. 8. The Patient-Patient-Centered Outcomes Research; 2015. p. 373\u201384."},{"issue":"1","key":"4179_CR107","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/ije\/dyn147","volume":"38","author":"PR Burton","year":"2009","unstructured":"Burton PR, et al. Size matters: just how big is big? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38(1):263\u201373.","journal-title":"Int J Epidemiol"},{"key":"4179_CR108","doi-asserted-by":"publisher","first-page":"112736","DOI":"10.1016\/j.socscimed.2019.112736","volume":"246","author":"EW de Bekker-Grob","year":"2020","unstructured":"de Bekker-Grob EW, et al. Can healthcare choice be predicted using stated preference data? Soc Sciamp; Med. 2020;246:112736.","journal-title":"Soc Sciamp; Med"},{"issue":"25","key":"4179_CR109","doi-asserted-by":"publisher","first-page":"769","DOI":"10.15585\/mmwr.mm6925a1","volume":"69","author":"S Ellington","year":"2020","unstructured":"Ellington S, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status-United States, January 22-june 7, 2020. Morbidity And Mortal Wkly Report. 2020;69(25):769.","journal-title":"Morbidity And Mortal Wkly Report"},{"issue":"2","key":"4179_CR110","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3390\/nu15020320","volume":"15","author":"H Siblini","year":"2023","unstructured":"Siblini H, et al. Assessing the hepatic safety of epigallocatechin gallate (EGCG) in reproductive-aged women. Nutrients. 2023;15(2):320.","journal-title":"Nutrients"},{"issue":"1","key":"4179_CR111","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/14647273.2023.2181710","volume":"26","author":"PS Hasdemir","year":"2023","unstructured":"Hasdemir PS, et al. The effect of COVID-19 vaccinations on menstrual cycle and serum anti-Mullerian hormone levels in reproductive age women. Hum Fertil. 2023;26(1):153\u201361.","journal-title":"Hum Fertil"},{"key":"4179_CR112","volume-title":"Seminars in perinatology","author":"BL Therrell","year":"2015","unstructured":"Therrell BL, et al. Current status of newborn screening worldwide: 2015. In: Seminars in perinatology. Elsevier; 2015."},{"issue":"6","key":"4179_CR113","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/MOP.0000000000000544","volume":"29","author":"C Limwongse","year":"2017","unstructured":"Limwongse C. Medical genetic services in a developing country: lesson from Thailand. Curr Opin In Pediatrics. 2017;29(6):634\u201339.","journal-title":"Curr Opin In Pediatrics"},{"issue":"1","key":"4179_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01804-6","volume":"16","author":"MJ Hosen","year":"2021","unstructured":"Hosen MJ, et al. Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation. Orphanet J Rare Dis. 2021;16(1):1\u201315.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"4179_CR115","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S2213-2600(19)30337-6","volume":"8","author":"SC Bell","year":"2020","unstructured":"Bell SC, et al. The future of cystic fibrosis care: a global perspective. The Lancet Respir Med. 2020;8(1):65\u2013124.","journal-title":"The Lancet Respir Med"},{"key":"4179_CR116","first-page":"37","volume":"38","author":"LVRF da Silva","year":"2021","unstructured":"da Silva LVRF, et al. Cystic fibrosis in low and middle-income countries (LMIC): a view from four different regions of the world. Paediatric Respir Rev. 2021;38:37\u201344.","journal-title":"Paediatric Respir Rev"},{"key":"4179_CR117","doi-asserted-by":"crossref","unstructured":"Ware RE, Odame I. Newborn screening with sickle cell point of care: a valuable resource in low-income settings. Pediatrics. 2019;144(4).","DOI":"10.1542\/peds.2019-1681"},{"key":"4179_CR118","doi-asserted-by":"crossref","unstructured":"Chung YS, Park S-K. Current status of newborn hearing screening in low-income families in the southeastern region of Korea. Epidemiol and Health. 2018;40.","DOI":"10.4178\/epih.e2018044"},{"key":"4179_CR119","doi-asserted-by":"crossref","unstructured":"Seyi-Olajide JO, et al. Screening methods for congenital anomalies in low and lower-middle income countries: a systematic review. J Pediatr Surg. 2023.","DOI":"10.1016\/j.jpedsurg.2023.01.038"},{"issue":"5","key":"4179_CR120","doi-asserted-by":"publisher","first-page":"e249997","DOI":"10.1136\/bcr-2022-249997","volume":"16","author":"S Bin","year":"2023","unstructured":"Bin S, Phou K, Im S. Primary congenital hypothyroidism: challenges in a low-income country without paediatric endocrinologist and universal newborn screening. BMJ Case Rep CP. 2023;16(5):e249997.","journal-title":"BMJ Case Rep CP"},{"key":"4179_CR121","doi-asserted-by":"crossref","unstructured":"Groulx-Boivin E, et al. Variability in newborn screening across Canada: spinal muscular atrophy and beyond (P4-9.002). AAN Enterprises. 2023.","DOI":"10.1212\/WNL.0000000000203295"},{"key":"4179_CR122","doi-asserted-by":"crossref","unstructured":"Jakhelln Laugen N, et al. Newborn hearing screening and intervention in children with unilateral hearing impairment: clinical practices in three nordic countries. 2021.","DOI":"10.3390\/jcm10215152"},{"issue":"10300","key":"4179_CR123","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/S0140-6736(21)00534-1","volume":"398","author":"M Balaj","year":"2021","unstructured":"Balaj M, et al. Parental education and inequalities in child mortality: a global systematic review and meta-analysis. The Lancet. 2021;398(10300):608\u201320.","journal-title":"The Lancet"},{"key":"4179_CR124","first-page":"100496","volume-title":"Inequities in newborn screening: race and the role of medicaid\u2606","author":"H Sohn","year":"2019","unstructured":"Sohn H, Timmermans S. Inequities in newborn screening: race and the role of medicaid\u2606. Vol. 9. SSM-Population Health; 2019. p. 100496."},{"issue":"2","key":"4179_CR125","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1136\/thoraxjnl-2019-213179","volume":"75","author":"DK Schl\u00fcter","year":"2020","unstructured":"Schl\u00fcter DK, et al. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: a UK cf registry-based study. Thorax. 2020;75(2):123\u201331.","journal-title":"Thorax"},{"issue":"1","key":"4179_CR126","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/2229-5070.175024","volume":"7","author":"J Mandal","year":"2017","unstructured":"Mandal J, Ponnambath DK, Parija SC. Bioethics: a brief review. Trop Parasitol. 2017;7(1):5.","journal-title":"Trop Parasitol"},{"issue":"4","key":"4179_CR127","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/dewb.12249","volume":"20","author":"J Barugahare","year":"2020","unstructured":"Barugahare J, Kutyabami P. Nature and history of the CIOMS International ethical guidelines and implications for local implementation: a perspective from East Africa. Dev World Bioethics. 2020;20(4):175\u201383.","journal-title":"Dev World Bioethics"},{"key":"4179_CR128","doi-asserted-by":"crossref","unstructured":"Fayemi AK, Macaulay-Adeyelure O. Decolonizing bioethics in Africa. BEOnline: journal of the West African bioethics training program. 2016;3(4):68.","DOI":"10.20541\/beonline.2016.0009"},{"issue":"5","key":"4179_CR129","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/jme-2022-108291","volume":"49","author":"B Pratt","year":"2023","unstructured":"Pratt B, de Vries J. Where is knowledge from the global south? An account of epistemic justice for a global bioethics. J Med Ethics. 2023;49(5):325\u201334.","journal-title":"J Med Ethics"},{"issue":"8","key":"4179_CR130","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S2213-2600(16)00053-9","volume":"4","author":"C Castellani","year":"2016","unstructured":"Castellani C, et al. Newborn screening for cystic fibrosis. Lancet Respir Med. 2016;4(8):653\u201361.","journal-title":"The Lancet Respir Med"},{"issue":"10091","key":"4179_CR131","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware RE, et al. Sickle cell disease. The Lancet. 2017;390(10091):311\u201323.","journal-title":"The Lancet"},{"issue":"1","key":"4179_CR132","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1080\/18387357.2019.1651661","volume":"18","author":"VA Green","year":"2020","unstructured":"Green VA. Parental reaction to diagnosis of infant hearing loss. Adv Ment Health. 2020;18(1):62\u201372.","journal-title":"Adv Ment Health"},{"issue":"1","key":"4179_CR133","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ymgme.2019.11.008","volume":"129","author":"R Sadat","year":"2020","unstructured":"Sadat R, et al. Increased parental anxiety and a benign clinical course: infants identified with short-chain acyl-CoA dehydrogenase deficiency and isobutyryl-CoA dehydrogenase deficiency through newborn screening in Georgia. Mol Genet Metab. 2020;129(1):20\u201325.","journal-title":"Mol Genet And Metab"},{"issue":"12","key":"4179_CR134","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1080\/14992027.2016.1215560","volume":"55","author":"R Ravi","year":"2016","unstructured":"Ravi R, et al. Knowledge and attitude of parents\/caregivers towards hearing loss and screening in newborns-a systematic review. Int J Audiol. 2016;55(12):715\u201322.","journal-title":"Int J Audiol"},{"issue":"5","key":"4179_CR135","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/cen.14562","volume":"95","author":"KR Rosettenstein","year":"2021","unstructured":"Rosettenstein KR, et al. A systematic review of the outcomes of false-positive results on newborn screening for congenital hypothyroidism. Clin Endocrinol. 2021;95(5):766\u201381.","journal-title":"Clin Endocrinol"},{"key":"4179_CR136","first-page":"334","volume":"1","author":"A Vernooij-van Langen","year":"2014","unstructured":"Vernooij-van Langen A, et al. Parental knowledge reduces long term anxiety induced by false-positive test results after newborn screening for cystic fibrosis. Mol Genet And Metab Rep. 2014;1:334\u201344.","journal-title":"Mol Genet And Metab Rep"},{"issue":"3","key":"4179_CR137","first-page":"250","volume":"63","author":"E Zaunseder","year":"2022","unstructured":"Zaunseder E, et al. Opportunities and challenges in machine learning-based newborn screening-a systematic literature review. JIMD Rep. 2022;63(3):250\u201361.","journal-title":"JIMD Rep"},{"issue":"1","key":"4179_CR138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-015-0010-3","volume":"16","author":"R Davies","year":"2015","unstructured":"Davies R, Ives J, Dunn M. A systematic review of empirical bioethics methodologies. BMC Med Ethics. 2015;16(1):1\u201313.","journal-title":"BMC Med Ethics"},{"issue":"1","key":"4179_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12910-019-0428-0","volume":"20","author":"R Huxtable","year":"2019","unstructured":"Huxtable R, Ives J. Mapping, framing, shaping: a framework for empirical bioethics research projects. BMC Med Ethics. 2019;20(1):1\u20138.","journal-title":"BMC Med Ethics"},{"issue":"6","key":"4179_CR140","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/15265161.2020.1863508","volume":"21","author":"G Pavarini","year":"2021","unstructured":"Pavarini G, et al. Design bioethics: a theoretical framework and argument for innovation in bioethics research. Am J Bioethics. 2021;21(6):37\u201350.","journal-title":"The Am J Bioethics"},{"issue":"1","key":"4179_CR141","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12910-022-00853-1","volume":"23","author":"G Samuel","year":"2022","unstructured":"Samuel G, et al. Ethical preparedness in health research and care: the role of behavioural approaches. BMC Med Ethics. 2022;23(1):115.","journal-title":"BMC Med Ethics"},{"issue":"3","key":"4179_CR142","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/s41436-018-0101-x","volume":"21","author":"AJ Goldenberg","year":"2019","unstructured":"Goldenberg AJ, et al. Including ELSI research questions in newborn screening pilot studies. Genet in Med. 2019;21(3):525\u201333.","journal-title":"Genet in Med"},{"issue":"11","key":"4179_CR143","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41431-022-01170-2","volume":"30","author":"J Gereis","year":"2022","unstructured":"Gereis J, et al. Parents\u2019 understanding of genome and exome sequencing for pediatric health conditions: a systematic review. Eur J Hum Genet. 2022;30(11):1216\u201325.","journal-title":"Eur J Hum Genet"},{"key":"4179_CR144","doi-asserted-by":"publisher","first-page":"701988","DOI":"10.3389\/fgene.2021.701988","volume":"12","author":"J Kruse","year":"2022","unstructured":"Kruse J, et al. Genetic testing for rare diseases: a systematic review of ethical aspects. Front Genet. 2022;12:701988.","journal-title":"Front Genet"},{"issue":"3","key":"4179_CR145","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1001\/jama.2024.19662","volume":"333","author":"A Ziegler","year":"2025","unstructured":"Ziegler A, et al. Expanded newborn screening using genome sequencing for early actionable conditions. Jama. 2025;333(3):232\u201340.","journal-title":"Jama"},{"issue":"3","key":"4179_CR146","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/ijns10030042","volume":"10","author":"AJ Ashenden","year":"2024","unstructured":"Ashenden AJ, et al. The multi-omic approach to newborn screening: opportunities and challenges. Int J Neonatal Screening. 2024;10(3):42.","journal-title":"Int J Neonatal Screening"},{"key":"4179_CR147","doi-asserted-by":"publisher","first-page":"867371","DOI":"10.3389\/fgene.2022.867371","volume":"13","author":"B Armstrong","year":"2022","unstructured":"Armstrong B, et al. Parental attitudes toward standard newborn screening and newborn genomic sequencing: findings from the BabySeq study. Front Genet. 2022;13:867371.","journal-title":"Front Genet"},{"issue":"2","key":"4179_CR148","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41431-023-01497-4","volume":"32","author":"B Prosenc","year":"2024","unstructured":"Prosenc B, et al. Perception of genomic newborn screening among peripartum mothers. Eur J Hum Genet. 2024;32(2):163\u201370.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4179_CR149","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijns11010014","volume":"11","author":"C Cazzorla","year":"2025","unstructured":"Cazzorla C, et al. Newborn screening for Gaucher disease: parental stress and psychological burden. Int J Neonatal Screening. 2025;11(1):14.","journal-title":"Int J Neonatal Screening"},{"issue":"9","key":"4179_CR150","doi-asserted-by":"publisher","first-page":"e0305110","DOI":"10.1371\/journal.pone.0305110","volume":"19","author":"CO Okeke","year":"2024","unstructured":"Okeke CO, et al. Sustainability of newborn screening for sickle cell disease in resource-poor countries: a systematic review. PLoS One. 2024;19(9):e0305110.","journal-title":"PLoS One"},{"issue":"4","key":"4179_CR151","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.ajhg.2025.02.018","volume":"112","author":"SM Kerr","year":"2025","unstructured":"Kerr SM, et al. Actionable genetic variants in 4, 198 Scottish participants from the Orkney and Shetland founder populations and implementation of return of results. The Am J Hum Genet. 2025;112(4):793\u2013807.","journal-title":"The Am J Hum Genet"},{"key":"4179_CR152","doi-asserted-by":"crossref","unstructured":"Kemper AR, et al. Newborn screening for Pompe disease: synthesis of the evidence and development of screening recommendations. Pediatrics. 2007 1334;120(5):e1327\u2013e.","DOI":"10.1542\/peds.2007-0388"},{"issue":"7","key":"4179_CR153","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/GIM.0b013e3181e38fb6","volume":"12","author":"MK Hill","year":"2010","unstructured":"Hill MK, et al. A systematic review of population screening for fragile X syndrome. Genet in Med. 2010;12(7):396\u2013410.","journal-title":"Genet in Med"},{"issue":"7","key":"4179_CR154","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/genes14071377","volume":"14","author":"K Aragon-Gawinska","year":"2023","unstructured":"Aragon-Gawinska K, et al. Spinal muscular atrophy treatment in patients identified by newborn screening-A systematic review. Genes. 2023;14(7):1377.","journal-title":"Genes"},{"key":"4179_CR155","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinbiochem.2021.09.010","volume":"98","author":"KC de Freitas Nakata","year":"2021","unstructured":"de Freitas Nakata KC, da Silva Pereira PP, Riveros BS. Creatine kinase test diagnostic accuracy in neonatal screening for Duchenne muscular dystrophy: a systematic review. Clin Biochem. 2021;98:1\u20139.","journal-title":"Clin Biochem"},{"key":"4179_CR156","first-page":"126","volume-title":"Acceptability of childhood screening: a systematic narrative review","author":"J Carlton","year":"2021","unstructured":"Carlton J, et al. Acceptability of childhood screening: a systematic narrative review. Vol. 193. Public Health; 2021. p. 126\u201338."},{"key":"4179_CR157","volume-title":"Eighth","author":"TL Beauchamp","year":"2019","unstructured":"Beauchamp TL, Childress JF. Principles of biomedical Ethics. In: Eighth. Oxford University Press; 2019."},{"issue":"1","key":"4179_CR158","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12687-018-0371-7","volume":"10","author":"AJ Clarke","year":"2019","unstructured":"Clarke AJ, Wallgren-Pettersson C. Ethics in genetic counselling. J Community Genet. 2019;10(1):3\u201333.","journal-title":"J Community Genet"},{"issue":"4","key":"4179_CR159","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/s41436-020-01038-0","volume":"23","author":"JS Richardson","year":"2021","unstructured":"Richardson JS, et al. Health and economic outcomes of newborn screening for infantile-onset Pompe disease. Genet in Med. 2021;23(4):758\u201366.","journal-title":"Genet in Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04179-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:17:45Z","timestamp":1781626665000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":159,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4179"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04179-0","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This paper has undergone the regular internal 45-day review process by the entire Screen4Care Consortium, including the Project Coordinator and Project Lead, in accordance with the Consortium Agreement, and has been subsequently approved. The Screen4Care Consortium and the two Scientific Coordinators have approved the paper, including authorship, content, and methods, and endorse its conclusions.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}